These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 17624924

  • 21. Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase.
    Bai VU, Cifuentes E, Menon M, Barrack ER, Reddy GP.
    J Cell Physiol; 2005 Aug; 204(2):381-7. PubMed ID: 15887248
    [Abstract] [Full Text] [Related]

  • 22. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
    Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM.
    Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
    [Abstract] [Full Text] [Related]

  • 23. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 24. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M.
    Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404
    [Abstract] [Full Text] [Related]

  • 25. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 26. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
    Koochekpour S, Lee TJ, Wang R, Sun Y, Delorme N, Hiraiwa M, Grabowski GA, Culig Z, Minokadeh A.
    J Cell Biochem; 2007 Jun 01; 101(3):631-41. PubMed ID: 17171640
    [Abstract] [Full Text] [Related]

  • 27. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Serda RE, Bisoffi M, Thompson TA, Ji M, Omdahl JL, Sillerud LO.
    Prostate; 2008 May 15; 68(7):773-83. PubMed ID: 18247401
    [Abstract] [Full Text] [Related]

  • 28. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 29. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.
    Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ.
    Mol Cell Endocrinol; 2011 Jan 01; 331(1):57-65. PubMed ID: 20728506
    [Abstract] [Full Text] [Related]

  • 30. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH.
    Cancer Res; 2004 Dec 15; 64(24):9185-92. PubMed ID: 15604291
    [Abstract] [Full Text] [Related]

  • 31. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR, Gao C, Furusato B, Chen Y, Shaheduzzaman S, Ravindranath L, Osborn DJ, Rosner IL, Dobi A, McLeod DG, Sesterhenn IA, Srivastava S, Cullen J, Petrovics G.
    Clin Cancer Res; 2008 Feb 01; 14(3):758-63. PubMed ID: 18245536
    [Abstract] [Full Text] [Related]

  • 32. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
    Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB.
    Prostate; 2007 Jul 01; 67(10):1091-8. PubMed ID: 17477366
    [Abstract] [Full Text] [Related]

  • 33. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y, Chen SY, Ross KN, Balk SP.
    Cancer Res; 2006 Aug 01; 66(15):7783-92. PubMed ID: 16885382
    [Abstract] [Full Text] [Related]

  • 34. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F, Langenstroer P, Zhang G, Iwamoto Y, See W.
    J Urol; 2003 Nov 01; 170(5):2009-13. PubMed ID: 14532843
    [Abstract] [Full Text] [Related]

  • 35. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 01; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 36. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
    Gravina GL, Marampon F, Di Staso M, Bonfili P, Vitturini A, Jannini EA, Pestell RG, Tombolini V, Festuccia C.
    Prostate; 2010 Aug 01; 70(11):1166-78. PubMed ID: 20333699
    [Abstract] [Full Text] [Related]

  • 37. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
    Church DR, Lee E, Thompson TA, Basu HS, Ripple MO, Ariazi EA, Wilding G.
    Prostate; 2005 May 01; 63(2):155-68. PubMed ID: 15486991
    [Abstract] [Full Text] [Related]

  • 38. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, Ikeda K, Urano T, Kawazu C, Hasegawa A, Ikeo K, Gojyobori T, Ouchi Y, Hayashizaki Y, Aburatani H, Inoue S.
    Oncogene; 2011 Feb 03; 30(5):619-30. PubMed ID: 20890304
    [Abstract] [Full Text] [Related]

  • 39. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J, Xie B, Capodice JL, Katz AE.
    Prostate; 2012 Feb 03; 72(3):244-52. PubMed ID: 21656835
    [Abstract] [Full Text] [Related]

  • 40. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S, Maggiolini M.
    Int J Biochem Cell Biol; 2009 Mar 03; 41(3):603-14. PubMed ID: 18692155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.